Brain wave study probes new Drug's power against ketamine
NCT ID NCT05049343
First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 19 times
Summary
This early-stage study tested an experimental drug called SAGE-904 in 22 healthy adults to see how it affects brain electrical activity. Participants received either the drug or a placebo, then were given ketamine to temporarily mimic certain brain changes. The goal was to measure brain wave patterns, not to treat any disease, and to check safety and tolerability.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sage Investigational Site
Newark, New Jersey, 07103, United States
Conditions
Explore the condition pages connected to this study.